Proteases

US6927056B2 · kind B2 · utility

Assignee

• Incyte Corporation · US

Inventors

• Stephen Todd · San Francisco, US
• Angelo Delegeane · Hayward, US
• Ameena Gandhi · San Francisco, US
• Danniel Nguyen · San Jose, US
• April Hafalia · Pacifica, US
• Liam Kearney · San Francisco, US
• Yan Lu · Mountain View, US
• Ernestine Lee · Kensington, US
• Narinder Chawla · Union City, US
• Debopriya Das · Mountain View, US
• Chandra Arvizu · San Diego, US
• Monique Yao · Mountain View, US
• Deborah Kallick · Stanford, US
• Vicki Elliott · San Jose, US
• Li Ding · Creve Coeur, US
• Henry Yue · Sunnyvale, US
• Roopa Reddy · Sunnyvale, US
• Dyung Lu · San Jose, US
• Jayalaxmi Ramkumar · Fremont, US
• Junming Yang · San Jose, US
• Catherine Tribouley · San Francisco, US
• Neil Burford · Durham, US
• Mariah Baughn · San Jose, US
• Preeti Lal · Sunnyvale, US
• Mark Borowsky · Needham, US
• Farrah Khan · Des Plaines, US
• Rajagopal Gururajan · San Jose, US
• Y. Tang · Sunnyvale, US
• Janice Au-Young · Brisbane, US
• Bridget Warren · Cupertino, US

Key dates

• Filing date: Sep 6, 2001
• Grant date: Aug 9, 2005
• Expiry date: Oct 5, 2021

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Biotechnology
• WIPO sector: Chemistry

Abstract

The invention provides a human cysteine proteases and polynucleotides which encode those proteases. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists, as well as methods for diagnosing, treating, or preventing disorders associated with aberrant expression of cysteine proteases.